3 results
Approved WMOWill not start
The primary objective is to determine the pharmacokinetic characteristics of galantamine after 2 single oral doses in children with Down syndrome. Secondary objectives are to evaluate safety and tolerability.
Approved WMOCompleted
The primary objective of this study is:* To evaluate the effects of filgotinib versus placebo for the treatment of signs and symptoms of rheumatoid arthritis (RA) as measured by the proportion of subjects achieving an American College of…
Approved WMOCompleted
The purpose of this study is to evaluate the feasibility of postoperative home monitoring for patients undergoing outpatient knee- or hip arthroplasty; discharged on the same day as surgery; less than 12-hour hospital stay.We hypothesise that a…